J. Erjefalt (Lund, Sweden), S. Siddiqui (Leicester, United Kingdom)
Blood cytotoxic/pro-inflammatory mediators in severe asthma
S. Hodge, G. Hodge, J. L. Simpson, I. Yang, J. Upham, A. James, P. G. Gibson, P. N. Reynolds (Adelaide, Newcastle, Brisbane, Perth, Australia)
|  |
Eosinophilic airway inflammation is associated with increased TLR2 and TLR4 expression in adult asthmatics
C. Porsbjerg, K. Baines, A. Sverrild, V. Backer, P. Gibson (Copenhagen, Denmark; Newcastle, Australia)
|  |
Imbalance of pro-inflammatory and anti-inflammatory markers on circulating dendritic cells in COPD
P. Stoll, M. Ulrich, K. Bratke, J. C. Virchow, M. Lommatzsch (Rostock, Germany)
| |
Involvement of purine metabolites in dsRNA-induced IL-33 expression in human bronchial smooth muscle cells
J. Calvén, H. Akbarshahi, M. Menzel, M. Idzko, L. Uller (Lund, Sweden; Freiburg, Germany)
| |
LSC 2014 abstract - RORgamma t-specific RNAi decreases allergic airway inflammation and airway hyperresponsiveness in a mouse model of neutrophilic asthma
S. Webering, L. Lunding, H. Fehrenbach, M. Wegmann (Borstel, Germany)
| |
TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells
L. Lunding, S. Webering, C. Vock, C. Hölscher, J. Behrends, H. Fehrenbach, M. Wegmann (Borstel, Germany)
| |
Versican, tenascin, periostin and IL-17A+ cells in severe asthma
D. S. Ferreira, R. Annoni, B. L. Oliveira, E. H. Katayama, R. M. Carvalho-Pinto, K. F. Rabe, A. Cukier, R. Stelmach, M. Dolhnikoff, T. Mauad (São Paulo, Brazil; Grosshansdorf, Germany)
| |
Elevated IL-17A in very severe COPD is localized to mast cells and correlates with lung function decline
A. Roos, L. Bjermer, M. Stampfli, J. Erjefält (Lund, Sweden; Hamilton, Canada)
| |